Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
Clinical trial NCT03756064 · UNKNOWN
Trial details
- NCT number
- NCT03756064
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2020-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.